Michel Toubeau
Overview
Explore the profile of Michel Toubeau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
538
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bonichon F, De Baere T, Berdelou A, Leboulleux S, Giraudet A, Cuinet M, et al.
Endocrine
. 2021 Mar;
72(3):798-808.
PMID: 33770383
Purpose: To determine efficacy and safety of thermal ablation (TA) for the local treatment of lung metastases of thyroid cancer. Methods: We retrospectively studied 47 patients from 10 centers treated...
2.
Depardon E, Kanoun S, Humbert O, Bertaut A, Riedinger J, Tal I, et al.
PLoS One
. 2018 Jul;
13(7):e0199529.
PMID: 30011328
Aim: Evaluate response and predict prognosis of patients with newly diagnosed metastatic breast cancer treated with first line systemic therapy using European Organization for Research and Treatment of Cancer (EORTC)...
3.
Barbolosi D, Summer I, Meille C, Serre R, Kelly A, Zerdoud S, et al.
Oncotarget
. 2017 Apr;
8(24):39167-39176.
PMID: 28389624
Purpose: Radioiodine therapy (RAI) has traditionally been used as treatment for metastatic thyroid cancer, based on its ability to concentrate iodine. Propositions to maximize tumor response with minimizing toxicity, must...
4.
Humbert O, Riedinger J, Vrigneaud J, Kanoun S, Dygai-Cochet I, Berriolo-Riedinger A, et al.
J Nucl Med
. 2016 Apr;
57(11):1707-1712.
PMID: 27103025
Methods: Forty-six consecutive women with triple-negative breast cancer and an indication for neoadjuvant chemotherapy were prospectively included. Women benefited from a baseline F-FDG PET examination with a 2-min chest-centered dynamic...
5.
Kanoun S, Rossi C, Berriolo-Riedinger A, Dygai-Cochet I, Cochet A, Humbert O, et al.
Eur J Nucl Med Mol Imaging
. 2014 May;
41(9):1735-43.
PMID: 24811577
Purpose: The presence of a bulky tumour at staging in Hodgkin lymphoma (HL) is a predictor of a poor outcome. The total metabolic tumour volume at baseline (TMTV0) computed on...
6.
Humbert O, Cochet A, Riedinger J, Berriolo-Riedinger A, Arnould L, Coudert B, et al.
Eur J Nucl Med Mol Imaging
. 2014 Mar;
41(8):1525-33.
PMID: 24647576
Purpose: To investigate the value of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET/CT) to predict a pathological complete response (pCR) after neoadjuvant chemotherapy (NAC) in women with human epidermal growth factor...
7.
Humbert O, Berriolo-Riedinger A, Cochet A, Gauthier M, Charon-Barra C, Guiu S, et al.
Eur J Nucl Med Mol Imaging
. 2013 Nov;
41(3):416-27.
PMID: 24258007
Purpose: The objective of this study was to evaluate, in the luminal human epidermal growth factor receptor 2 (HER2)-negative breast cancer subtype, the prognostic value of tumour glucose metabolism at...
8.
Cochet A, Dygai-Cochet I, Riedinger J, Humbert O, Berriolo-Riedinger A, Toubeau M, et al.
Eur J Nucl Med Mol Imaging
. 2013 Nov;
41(3):428-37.
PMID: 24196916
Purpose: The objective of this study was to assess the impact on management and the prognostic value of (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT for initial staging of newly diagnosed...
9.
Berthet L, Cochet A, Kanoun S, Berriolo-Riedinger A, Humbert O, Toubeau M, et al.
J Nucl Med
. 2013 May;
54(8):1244-50.
PMID: 23674577
Unlabelled: In newly diagnosed diffuse large B-cell lymphoma (DLBCL), the sensitivity of bone marrow biopsy (BMB) for the detection of bone marrow involvement (BMI) can be low because of sampling...
10.
Schvartz C, Bonnetain F, Dabakuyo S, Gauthier M, Cueff A, Fieffe S, et al.
J Clin Endocrinol Metab
. 2012 Feb;
97(5):1526-35.
PMID: 22344193
Context: American Thyroid Association and European Thyroid Association guidelines cannot recommend for or against radioactive iodine (RAI) ablation after surgery in low-risk differentiated thyroid cancer (DTC) patients. Objectives: The objective...